Viewing Study NCT06731218


Ignite Creation Date: 2025-12-25 @ 5:03 AM
Ignite Modification Date: 2025-12-26 @ 4:05 AM
Study NCT ID: NCT06731218
Status: RECRUITING
Last Update Posted: 2025-09-15
First Post: 2024-12-09
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase I Clinical Study to Evaluate the Safety and Efficacy of RGB-5088 in Patients With Type 1 Diabetes Mellitus
Sponsor: Hangzhou Reprogenix Bioscience, Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module